ID   CSK21_HUMAN             Reviewed;         391 AA.
AC   P68400; P19138; P20426; Q14013; Q5U065;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   05-OCT-2010, entry version 80.
DE   RecName: Full=Casein kinase II subunit alpha;
DE            Short=CK II alpha;
DE            EC=2.7.11.1;
GN   Name=CSNK2A1; Synonyms=CK2A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=89323123; PubMed=2752008; DOI=10.1021/bi00435a066;
RA   Meisner H., Heller-Harrison R., Buxton J., Czech M.P.;
RT   "Molecular cloning of the human casein kinase II alpha subunit.";
RL   Biochemistry 28:4072-4076(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=91070071; PubMed=2174700; DOI=10.1021/bi00488a034;
RA   Lozeman F.J., Litchfield D.W., Piening C., Takio K., Walsh K.A.,
RA   Krebs E.G.;
RT   "Isolation and characterization of human cDNA clones encoding the
RT   alpha and the alpha' subunits of casein kinase II.";
RL   Biochemistry 29:8436-8447(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=93131026; PubMed=8420794; DOI=10.1016/0014-5793(93)81197-8;
RA   Devilat I., Carvallo P.;
RT   "Structure and sequence of an intronless gene for human casein kinase
RT   II-alpha subunit.";
RL   FEBS Lett. 316:114-118(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=21638749; PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, Muscle, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH SSRP1 AND SUPT16H.
RX   PubMed=11239457; DOI=10.1016/S1097-2765(01)00176-9;
RA   Keller D.M., Zeng X., Wang Y., Zhang Q.H., Kapoor M., Shu H.,
RA   Goodman R., Lozano G., Zhao Y., Lu H.;
RT   "A DNA damage-induced p53 serine 392 kinase complex contains CK2,
RT   hSpt16, and SSRP1.";
RL   Mol. Cell 7:283-292(2001).
RN   [10]
RP   INTERACTION WITH SSRP1 AND SUPT16H.
RX   PubMed=12393879; DOI=10.1074/jbc.M209820200;
RA   Keller D.M., Lu H.;
RT   "p53 serine 392 phosphorylation increases after UV through induction
RT   of the assembly of the CK2.hSPT16.SSRP1 complex.";
RL   J. Biol. Chem. 277:50206-50213(2002).
RN   [11]
RP   INTERACTION WITH RNPS1.
RX   PubMed=15684395; DOI=10.1128/MCB.25.4.1446-1457.2005;
RA   Trembley J.H., Tatsumi S., Sakashita E., Loyer P., Slaughter C.A.,
RA   Suzuki H., Endo H., Kidd V.J., Mayeda A.;
RT   "Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2
RT   phosphorylation.";
RL   Mol. Cell. Biol. 25:1446-1457(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-194; SER-362 AND
RP   SER-370, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-7; TYR-50;
RP   TYR-125; THR-127; TYR-255; SER-277 AND SER-287, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-102, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 1-337, AND SUBUNIT.
RX   PubMed=11092945; DOI=10.1107/S0907444900013627;
RA   Niefind K., Guerra B., Ermakowa I., Issinger O.G.;
RT   "Crystallization and preliminary characterization of crystals of human
RT   protein kinase CK2.";
RL   Acta Crystallogr. D 56:1680-1684(2000).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 1-329.
RX   PubMed=14646071; DOI=10.1107/S0907444903018900;
RA   Pechkova E., Zanotti G., Nicolini C.;
RT   "Three-dimensional atomic structure of a catalytic subunit mutant of
RT   human protein kinase CK2.";
RL   Acta Crystallogr. D 59:2133-2139(2003).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 2-335.
RX   PubMed=12860116; DOI=10.1016/S0022-2836(03)00638-7;
RA   Ermakova I., Boldyreff B., Issinger O.G., Niefind K.;
RT   "Crystal structure of a C-terminal deletion mutant of human protein
RT   kinase CK2 catalytic subunit.";
RL   J. Mol. Biol. 330:925-934(2003).
CC   -!- FUNCTION: Casein kinases are operationally defined by their
CC       preferential utilization of acidic proteins such as caseins as
CC       substrates. The alpha and alpha' chains contain the catalytic
CC       site. Participates in Wnt signaling. CK2 phosphorylates 'Ser-392'
CC       of p53/TP53 following UV irradiation.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Tetramer composed of an alpha chain, an alpha' and two
CC       beta chains. Also component of a CK2-SPT16-SSRP1 complex composed
CC       of SSRP1, SUPT16H, CSNK2A1, CSNK2A2 and CSNK2B, the complex
CC       associating following UV irradiation. Interacts with RNPS1.
CC   -!- INTERACTION:
CC       P49407:ARRB1; NbExp=1; IntAct=EBI-347804, EBI-743313;
CC       P67870:CSNK2B; NbExp=3; IntAct=EBI-347804, EBI-348169;
CC       O60282:KIF5C; NbExp=2; IntAct=EBI-347804, EBI-717170;
CC       P29590:PML; NbExp=2; IntAct=EBI-347804, EBI-295890;
CC       Q15287:RNPS1; NbExp=1; IntAct=EBI-347804, EBI-395959;
CC       Q01105:SET; NbExp=1; IntAct=EBI-347804, EBI-1053182;
CC       Q01082:SPTBN1; NbExp=1; IntAct=EBI-347804, EBI-351561;
CC       P31946:YWHAB; NbExp=1; IntAct=EBI-347804, EBI-359815;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. CK2 subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02853; AAA56821.1; -; mRNA.
DR   EMBL; M55265; AAA35503.1; -; mRNA.
DR   EMBL; X70251; CAA49758.1; -; Genomic_DNA.
DR   EMBL; S53149; ABB72474.1; -; mRNA.
DR   EMBL; BT019792; AAV38595.1; -; mRNA.
DR   EMBL; AB451279; BAG70093.1; -; mRNA.
DR   EMBL; AL049761; CAB65624.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10665.1; -; Genomic_DNA.
DR   EMBL; BC011668; AAH11668.1; -; mRNA.
DR   EMBL; BC053532; AAH53532.1; -; mRNA.
DR   EMBL; BC071167; AAH71167.1; -; mRNA.
DR   IPI; IPI00744507; -.
DR   PIR; A30319; A30319.
DR   RefSeq; NP_001886.1; -.
DR   RefSeq; NP_808227.1; -.
DR   RefSeq; NP_808228.1; -.
DR   UniGene; Hs.644056; -.
DR   UniGene; Hs.654675; -.
DR   PDB; 1JWH; X-ray; 3.10 A; A/B=1-337.
DR   PDB; 1NA7; X-ray; 2.40 A; A=1-329.
DR   PDB; 1PJK; X-ray; 2.50 A; A=2-335.
DR   PDB; 2PVR; X-ray; 1.60 A; A=2-335.
DR   PDB; 2ZJW; X-ray; 2.40 A; A=1-335.
DR   PDB; 3BQC; X-ray; 1.50 A; A=1-335.
DR   PDB; 3C13; X-ray; 1.95 A; A=1-335.
DR   PDB; 3FWQ; X-ray; 2.30 A; A/B=1-335.
DR   PDB; 3H30; X-ray; 1.56 A; A/B=1-334.
DR   PDB; 3JUH; X-ray; 1.66 A; A/B=1-335.
DR   PDB; 3MB6; X-ray; 1.75 A; A=1-331.
DR   PDB; 3MB7; X-ray; 1.65 A; A=1-331.
DR   PDBsum; 1JWH; -.
DR   PDBsum; 1NA7; -.
DR   PDBsum; 1PJK; -.
DR   PDBsum; 2PVR; -.
DR   PDBsum; 2ZJW; -.
DR   PDBsum; 3BQC; -.
DR   PDBsum; 3C13; -.
DR   PDBsum; 3FWQ; -.
DR   PDBsum; 3H30; -.
DR   PDBsum; 3JUH; -.
DR   PDBsum; 3MB6; -.
DR   PDBsum; 3MB7; -.
DR   ProteinModelPortal; P68400; -.
DR   DIP; DIP-32682N; -.
DR   IntAct; P68400; 38.
DR   MINT; MINT-142347; -.
DR   STRING; P68400; -.
DR   PhosphoSite; P68400; -.
DR   PRIDE; P68400; -.
DR   Ensembl; ENST00000217244; ENSP00000217244; ENSG00000101266.
DR   Ensembl; ENST00000349736; ENSP00000339247; ENSG00000101266.
DR   GeneID; 1457; -.
DR   KEGG; hsa:1457; -.
DR   UCSC; uc002wdw.1; human.
DR   CTD; 1457; -.
DR   GeneCards; GC20M000414; -.
DR   H-InvDB; HIX0015555; -.
DR   HGNC; HGNC:2457; CSNK2A1.
DR   HPA; CAB020680; -.
DR   MIM; 115440; gene.
DR   PharmGKB; PA26957; -.
DR   eggNOG; prNOG12460; -.
DR   HOVERGEN; HBG107282; -.
DR   PhylomeDB; P68400; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; alphasynuclein_pathway; Alpha-synuclein signaling.
DR   Pathway_Interaction_DB; nfkappabatypicalpathway; Atypical NF-kappaB pathway.
DR   Pathway_Interaction_DB; bcr_5pathway; BCR signaling pathway.
DR   Pathway_Interaction_DB; wnt_canonical_pathway; Canonical Wnt signaling pathway.
DR   Pathway_Interaction_DB; lis1pathway; Lissencephaly gene (LIS1) in neuronal migration and development.
DR   Pathway_Interaction_DB; pdgfrapathway; PDGFR-alpha signaling pathway.
DR   Pathway_Interaction_DB; ps1pathway; Presenilin action in Notch and Wnt signaling.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; p38alphabetadownstreampathway; Signaling mediated by p38-alpha and p38-beta.
DR   Reactome; REACT_18266; Axon guidance.
DR   NextBio; 5989; -.
DR   ArrayExpress; P68400; -.
DR   Bgee; P68400; -.
DR   CleanEx; HS_CSNK2A1; -.
DR   Genevestigator; P68400; -.
DR   GermOnline; ENSG00000101266; Homo sapiens.
DR   GO; GO:0016581; C:NuRD complex; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:ProtInc.
DR   GO; GO:0016580; C:Sin3 complex; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0016055; P:Wnt receptor signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Serine/threonine-protein kinase;
KW   Transferase; Wnt signaling pathway.
FT   CHAIN         1    391       Casein kinase II subunit alpha.
FT                                /FTId=PRO_0000085883.
FT   DOMAIN       39    324       Protein kinase.
FT   NP_BIND      45     53       ATP (By similarity).
FT   ACT_SITE    156    156       Proton acceptor.
FT   BINDING      68     68       ATP (By similarity).
FT   MOD_RES       2      2       Phosphoserine.
FT   MOD_RES       7      7       Phosphoserine.
FT   MOD_RES      50     50       Phosphotyrosine.
FT   MOD_RES     102    102       N6-acetyllysine.
FT   MOD_RES     125    125       Phosphotyrosine.
FT   MOD_RES     127    127       Phosphothreonine.
FT   MOD_RES     194    194       Phosphoserine.
FT   MOD_RES     255    255       Phosphotyrosine.
FT   MOD_RES     277    277       Phosphoserine.
FT   MOD_RES     287    287       Phosphoserine.
FT   MOD_RES     362    362       Phosphoserine.
FT   MOD_RES     370    370       Phosphoserine.
FT   CONFLICT    128    128       L -> F (in Ref. 3; CAA49758).
FT   CONFLICT    256    256       D -> G (in Ref. 3; CAA49758).
FT   CONFLICT    287    287       S -> R (in Ref. 3; CAA49758).
FT   CONFLICT    351    351       M -> V (in Ref. 3; CAA49758).
FT   STRAND       10     12
FT   HELIX        15     18
FT   HELIX        21     24
FT   HELIX        26     28
FT   HELIX        36     38
FT   STRAND       39     47
FT   STRAND       49     58
FT   TURN         59     61
FT   STRAND       64     70
FT   HELIX        75     87
FT   STRAND       97    102
FT   TURN        104    106
FT   STRAND      108    113
FT   HELIX       121    124
FT   HELIX       130    149
FT   HELIX       159    161
FT   STRAND      162    165
FT   TURN        166    169
FT   STRAND      170    173
FT   HELIX       195    197
FT   HELIX       200    203
FT   HELIX       212    227
FT   STRAND      230    233
FT   HELIX       238    249
FT   HELIX       252    260
FT   HELIX       267    270
FT   TURN        281    284
FT   TURN        287    289
FT   HELIX       290    292
FT   HELIX       295    304
FT   HELIX       315    319
FT   HELIX       322    324
SQ   SEQUENCE   391 AA;  45144 MW;  D3B6F5D13FF7422D CRC64;
     MSGPVPSRAR VYTDVNTHRP REYWDYESHV VEWGNQDDYQ LVRKLGRGKY SEVFEAINIT
     NNEKVVVKIL KPVKKKKIKR EIKILENLRG GPNIITLADI VKDPVSRTPA LVFEHVNNTD
     FKQLYQTLTD YDIRFYMYEI LKALDYCHSM GIMHRDVKPH NVMIDHEHRK LRLIDWGLAE
     FYHPGQEYNV RVASRYFKGP ELLVDYQMYD YSLDMWSLGC MLASMIFRKE PFFHGHDNYD
     QLVRIAKVLG TEDLYDYIDK YNIELDPRFN DILGRHSRKR WERFVHSENQ HLVSPEALDF
     LDKLLRYDHQ SRLTAREAME HPYFYTVVKD QARMGSSSMP GGSTPVSSAN MMSGISSVPT
     PSPLGPLAGS PVIAAANPLG MPVPAAAGAQ Q
//
